Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P51
Within normal range
vs 3Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.62% |
| Q3 2025 | 2.54% |
| Q2 2025 | 3.90% |
| Q1 2025 | -28.83% |
| Q4 2024 | 7.81% |
| Q3 2024 | -49.19% |
| Q2 2024 | 0.83% |
| Q1 2024 | 1.48% |
| Q4 2023 | -10.68% |
| Q3 2023 | 7.23% |
| Q2 2023 | -46.88% |
| Q1 2023 | -13.80% |
| Q4 2022 | 6.18% |
| Q3 2022 | 20.88% |
| Q2 2022 | -46.99% |
| Q1 2022 | 31.29% |
| Q4 2021 | -21.61% |
| Q3 2021 | -42.15% |
| Q2 2021 | -19.97% |
| Q1 2021 | 12.85% |
| Q4 2020 | -105.81% |
| Q3 2020 | -54.98% |
| Q2 2020 | -13.90% |
| Q1 2020 | -45.96% |
| Q4 2019 | 7.97% |
| Q3 2019 | -227.62% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2017 | -960.90% |
| Q3 2017 | 55.07% |
| Q2 2017 | -149.58% |
| Q1 2017 | 428.02% |
| Q4 2016 | 26.91% |
| Q3 2016 | 68.99% |
| Q2 2016 | -7930.00% |
| Q1 2016 | 92.54% |
| Q4 2015 | -458.33% |
| Q3 2015 | -106.19% |
| Q2 2015 | 315.56% |
| Q1 2015 | -276.47% |